Cargando…
Diagnostic and Therapeutic Pathway of Advanced Ovarian Cancer with Peritoneal Metastases
SIMPLE SUMMARY: As ovarian cancer represents the most lethal gynecological malignancy, the diagnostic process represents a crucial step in order to select the appropriate treatment strategy. Indeed, the association of tumor marker levels with radiological imaging and an evaluation of tumor load with...
Autores principales: | Ghirardi, Valentina, Fagotti, Anna, Ansaloni, Luca, Valle, Mario, Roviello, Franco, Sorrentino, Lorena, Accarpio, Fabio, Baiocchi, Gianluca, Piccini, Lorenzo, De Simone, Michele, Coccolini, Federico, Visaloco, Mario, Bacchetti, Stefano, Scambia, Giovanni, Marrelli, Daniele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856580/ https://www.ncbi.nlm.nih.gov/pubmed/36672356 http://dx.doi.org/10.3390/cancers15020407 |
Ejemplares similares
-
Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes
por: Marrelli, Daniele, et al.
Publicado: (2022) -
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer with Synchronous Peritoneal Metastases: Multicenter Study of ‘Italian Peritoneal Surface Malignancies Oncoteam—S.I.C.O.’
por: Marano, Luigi, et al.
Publicado: (2021) -
Diagnostic and Therapeutic Pathway in Diffuse Malignant Peritoneal Mesothelioma
por: Kusamura, Shigeki, et al.
Publicado: (2023) -
Bidirectional Approach with PIPAC and Systemic Chemotherapy for Patients with Synchronous Gastric Cancer Peritoneal Metastases (GCPM)
por: Casella, Francesco, et al.
Publicado: (2023) -
Repeated Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Selected Patients Affected by Peritoneal Metastases: Italian PSM Oncoteam Evidence
por: Pasqual, Enrico Maria, et al.
Publicado: (2023)